Respiratory therapeutic devices are designed to assist individuals with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders. Several companies in Europe are actively involved in the development and manufacturing of respiratory therapeutic devices.
Royal Philips acquires ResMed for sleep apnea diagnosis and treatment solutions: October 2023 collaboration combines expertise to develop integrated solutions for sleep apnea management, from diagnosis to continuous positive airway pressure (CPAP) therapy.
Cardinal Health purchases Aerogen Aeroneb Mesh Nebulizer business: November 2023 acquisition bolsters Cardinal Health's respiratory care portfolio, expanding their offerings for patients with chronic respiratory conditions requiring nebulizer therapy.
FDA approval of Sevoflurane for maintenance of anesthesia in pediatric patients: January 2024 approval by the US Food and Drug Administration has potential implications for the European market, expanding the reach of this commonly used inhalational anesthetic for children undergoing surgery in Europe.
List of Europe Respirtory Therapeutic Devices Key Companies in the Market
Europe Respiratory Therapeutic Devices Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)